Epigral Board Approves 125,000 TPA Epoxy Resin And Multi-Purpose Plant

27 July 2026

Epigral Ltd.

New capex: Epoxy Resin 125ktpa & MPP, H2FY28. Q1 rev 709cr, EBITDA 25%, vol +5%, util >80%, net debt/EBITDA 0.8x.

Recent Events

Epigral Q1 PAT Up 25%, Board Approves ₹600 Crore Epoxy Resin Capex

Get features of